Abstract
Silver nanoparticles stabilized by a well-known antibacterial surfactantbenzyldimethyl[3-(myristoylamino)propyl]ammonium chloride(Myramistin®) were produced for the first time by borohydride reduction of silver chloride sol in water.Stable aqueous dispersions of silver nanoparticles without evident precipitationfor several months could be obtained. In vitro bactericidal tests showed thatMyramistin® capped silver NPs exhibited notable activity against six differentmicroorganisms—gram-positive and gram-negative bacteria, yeasts and fungi.The activity was up to 20 times higher (against E. coli) compared toMyramistin® at the same concentrations and on average 2 times higher if compared with citrate-stabilizedNPs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
